Synopsis
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Parenteral
Solubilizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
46
PharmaCompass offers a list of Fluphenazine Decanoate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Fluphenazine Decanoate manufacturer or Fluphenazine Decanoate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fluphenazine Decanoate manufacturer or Fluphenazine Decanoate supplier.
A C07956 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of C07956, including repackagers and relabelers. The FDA regulates C07956 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. C07956 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of C07956 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A C07956 supplier is an individual or a company that provides C07956 active pharmaceutical ingredient (API) or C07956 finished formulations upon request. The C07956 suppliers may include C07956 API manufacturers, exporters, distributors and traders.
click here to find a list of C07956 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A C07956 DMF (Drug Master File) is a document detailing the whole manufacturing process of C07956 active pharmaceutical ingredient (API) in detail. Different forms of C07956 DMFs exist exist since differing nations have different regulations, such as C07956 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A C07956 DMF submitted to regulatory agencies in the US is known as a USDMF. C07956 USDMF includes data on C07956's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The C07956 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of C07956 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The C07956 Drug Master File in Japan (C07956 JDMF) empowers C07956 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the C07956 JDMF during the approval evaluation for pharmaceutical products. At the time of C07956 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of C07956 suppliers with JDMF on PharmaCompass.
A C07956 CEP of the European Pharmacopoeia monograph is often referred to as a C07956 Certificate of Suitability (COS). The purpose of a C07956 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of C07956 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of C07956 to their clients by showing that a C07956 CEP has been issued for it. The manufacturer submits a C07956 CEP (COS) as part of the market authorization procedure, and it takes on the role of a C07956 CEP holder for the record. Additionally, the data presented in the C07956 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the C07956 DMF.
A C07956 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. C07956 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of C07956 suppliers with CEP (COS) on PharmaCompass.
A C07956 written confirmation (C07956 WC) is an official document issued by a regulatory agency to a C07956 manufacturer, verifying that the manufacturing facility of a C07956 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting C07956 APIs or C07956 finished pharmaceutical products to another nation, regulatory agencies frequently require a C07956 WC (written confirmation) as part of the regulatory process.
click here to find a list of C07956 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing C07956 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for C07956 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture C07956 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain C07956 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a C07956 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of C07956 suppliers with NDC on PharmaCompass.
C07956 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of C07956 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right C07956 GMP manufacturer or C07956 GMP API supplier for your needs.
A C07956 CoA (Certificate of Analysis) is a formal document that attests to C07956's compliance with C07956 specifications and serves as a tool for batch-level quality control.
C07956 CoA mostly includes findings from lab analyses of a specific batch. For each C07956 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
C07956 may be tested according to a variety of international standards, such as European Pharmacopoeia (C07956 EP), C07956 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (C07956 USP).
